Abstract
Rod and cone photoreceptor neurons in the mammalian retina possess specialized cellular architecture and functional features for converting light to a neuronal signal. Establishing and maintaining these characteristics requires appropriate expression of a specific set of genes, which is tightly regulated by a network of photoreceptor transcription factors centered on the cone-rod homeobox protein CRX. CRX recruits transcription coactivators p300 and CBP to acetylate promoter-bound histones and activate transcription of target genes. To further elucidate the role of these two coactivators, we conditionally knocked out Ep300 and/or CrebBP in differentiating rods or cones, using opsin-driven Cre recombinase. Knockout of either factor alone exerted minimal effects, but loss of both factors severely disrupted target cell morphology and function: the unique nuclear chromatin organization seen in mouse rods was reversed, accompanied by redistribution of nuclear territories associated with repressive and active histone marks. Transcription of many genes including CRX targets was severely impaired, correlating with reduced histone H3/H4 acetylation (the products of p300/CBP) on target gene promoters. Interestingly, the presence of a single wild-type allele of either coactivator prevented many of these defects, with Ep300 more effective than Cbp. These results suggest that p300 and CBP play essential roles in maintaining photoreceptor-specific structure, function and gene expression.
Introduction
The mammalian retina consists of three layers of neurons specialized for light detection and initial processing of visual signals [1] [2]. Photoreceptors are located in the outer layer, and constitute 70% of retinal cells. These cells, which convert light to a neuronal signal, contain specific cellular structures including apical membrane specializations in the “outer segment” that capture light photons, ribbon-type synaptic specializations for transmitting neural signals to interneurons in the inner retinal layers, and a unique nuclear chromatin organization to mediate cell-type-specific gene expression while maximizing the amount of light reaching the outer segments. The vast majority of photoreceptors in most mammalian retinas are rods, which are exquisitely sensitive to low levels of light and mediate night vision. 3–5% of photoreceptors in mouse and human retinas are cones, which mediate color vision in daylight. Cones can be further classified on the basis of the wavelength sensitivity of the light-capturing visual pigment opsin they contain. To establish and maintain their structure and function, each photoreceptor subtype expresses a set of specific genes including the characteristic opsin, under the tight regulation of a network of photoreceptor-specific transcription factors [3] [4]. The central player, the cone-rod homeobox transcription factor CRX, interacts with photoreceptor subtype-specific transcription factors such as NRL and NR2E3 in rods or TRβ2 and RXRγ in cones, to activate or suppress expression of rod vs. cone gene sets. We demonstrated previously that CRX activates transcription by interacting with coactivators or coactivator complexes including CBP, P300, and GCN5 (KAT2A), a component of the STAGA chromatin remodeling complex [5] [8]. All of these coactivators contain intrinsic lysine acetyltransferase (KAT) activity, catalyzing acetylation of core histone tails and other proteins.
Acetylated histones are active marks for transcription, often associated with “open” chromatin that is accessible to the transcription machinery and transcription regulators [9] [10] [11] [12]. Histone acetylation is controlled by two classes of enzymes with opposing functions: Histone lysine (K) acetyltransferases (HATs) add the acetyl groups to specific lysine residues in the tails of core histones, and histone deacetylases (HDACs) remove them.
In mammals, there are four major families of HATs, whose members show high degrees of homology and, in some cases, functional redundancy (reviewed in [13] [14]). This is true for the well-studied KAT3 family members, “CREB Binding Protein” (CREBBP, CBP or KAT3A) [6] and the closely related “Adenovirus E1A-associated 300-kD Protein” (p300 or KAT3B) [7], which catalyze acetylation of all core histones, particularly H3 and H4 [15] [16] [17] [18]. In addition, CBP and p300 act as transcription coactivators by interacting with a variety of specific transcription factors and co-regulators [13] [19] to regulate the expression of numerous genes important in embryonic development [20], cell proliferation and differentiation [21] [22], neuronal function [23] [24] [25] [26] [27], energy homeostasis [20] [28] [29] [30], and tumor suppression [31] [32]. In humans, mutations in CBP or EP300 are associated with Rubinstein-Taybi syndrome (RSTS) (http://omim.org/entry/180849, http://omim.org/entry/613684), an autosomal-dominant disorder characterized by mental and growth retardation and skeletal abnormalities [33] [34]. Molecular mechanism studies have found that RSTS-causing mutations affect acetyltransferase catalytic activity and coactivator function [35] [36]. The importance of HAT catalytic activity was further supported by the finding that p300/CBP-mediated acetylation of histone H3 lysine 18/27 recruits RNA polymerase II to target gene promoters in response to ligand-induced nuclear receptor activation [11]. In mice, p300 and CBP are required for embryonic development and viability. Conventional knockout of either factor in mice is early embryonic lethal [37] [38], complicating investigation of the roles of p300/CBP in fetal development of specific tissues such as the nervous system. This limitation has been circumvented by Cre-loxP-mediated conditional knockout strategies, leading to the findings that p300 and CBP play redundant and distinct functions in thymocyte and T-cell development [19] [39], and that p300/CBP in the brain is required for formation of long-term memories [26]. However, the role of p300/CBP in the retina (a part of the central nervous system) is not clear, although retinal dystrophy and glaucoma are commonly seen in RSTS patients [40].
Results of several studies suggest that p300/CBP HATs may play important roles in retinal photoreceptor development and maintenance. First, both coactivators are expressed by developing and mature photoreceptors, and physically interact with the key photoreceptor transcription factor CRX [5] [41] [42]. Second, during photoreceptor development, both factors are found on the promoter/enhancer regions of CRX-regulated photoreceptor genes after CRX binds. These events are followed by acetylation of histone H3 and H4 on these promoters, recruitment of additional photoreceptor-specific transcription factors, and transcriptional activation of the associated genes [5]. Increases in H3 acetylation have also been associated with activation by NRL [43]. Third, in the absence of CRX (Crx−/− mouse retina), recruitment of CBP to target gene promoters and acetylated histone H3/H4 levels are reduced, correlating with decreased transcription [5]. To examine the role of p300/CBP in CRX-regulated photoreceptor gene expression, we conditionally knocked out Ep300 and/or Cbp in rods or cones of the mouse retina using either a rhodopsin or cone opsin promoter to drive Cre recombinase expression. Here we report that loss of both p300 and CBP, but neither alone, causes detrimental defects in rod/cone structure and function, maintenance of photoreceptor gene expression and cell identity. These defects are accompanied by drastically reduced acetylation of histone H3/H4 on photoreceptor genes, and loss of the nuclear chromatin organization pattern characteristic of mouse photoreceptors [44].
Results
Generation of photoreceptor-specific Ep300/Cbp conditional knockout mice
The desired conditional knockout mice listed in Table 1 were generated by crossing mice carrying floxed alleles of either Ep300 [19] or Cbp [39]. Each floxed allele contains two LoxP sites flanking a critical exon, and has been shown to result in depletion of the gene product in cells expressing Cre recombinase. To express Cre in either rods or cones, we obtained two Cre transgenic mouse lines, rhodopsin promoter driven-Cre (Rho-iCre or “RCre”, [45]) and human red-green cone opsin promoter driven-Cre (HRGP-Cre or “CCre”, [46]). Cre expression was confirmed by crossing these lines to ROSA-mTmG Cre reporter mice, which express membrane-bound green fluorescent protein (GFP) in the presence of CRE activity [47]. As expected, the “RCre; mTmG” mice express Cre in differentiated rods beginning at postnatal day 5 (P5), peaking at P12 and continuing through adulthood (Supplemental Fig. S1A) without affecting retinal morphology or function up to 30 weeks of age (data not shown). In contrast, the “CCre; mTmG” mice show typical cone patterns of Cre expression, starting in a few cells in the ONL at P5, peaking around P12, and continuing through adult ages, with CRE activity restricted to cells in the outer margin of the outer nuclear layer (ONL), where cone cell bodies reside (Supplemental Fig. S1B). The similar expression pattern in dorsal vs. ventral regions suggests that CCre-driven Cre is expressed in both M-cones (enriched in the dorsal retina) and S-cones (enriched in the ventral retina) (reviewed in [3]). CCre mice also have normal retinal morphology and function. RCre and CCre lines were then mated with mice carrying Ep300 flox, Cbp flox, or both, to generate mice with the various conditional knockout (CKO) genotypes listed in Table 1. All CKO mice are viable and healthy without apparent abnormalities. CRE-mediated loss of p300 or CBP in photoreceptors was confirmed by immunostaining using anti-p300 (Fig. 1I-L) or anti-CBP (Supplemental Fig. S1C) antibodies. Thus, we have successfully created conditional knockouts of Ep300, Cbp or both in either rods or cones.
Table 1. Genotypes of mice used in this study.
Cre | Flox Genotype | Designated |
Rho-iCre+ [45] | Ep300wt; Cbpwt | RCre+ |
Rho-iCre+ | Ep300wt; Cbpf/f [39] | CbpKO |
Rho-iCre+ | Ep300f/f [19]; Cbpwt | p300KO |
- | Ep300f/f; Cbpf/f | Cre neg |
Rho-iCre+ | Ep300f/f; Cbp+/f | Cbp CH |
Rho-iCre+ | Ep300+/f; Cbpf/f | P300 CH |
Rho-iCre+ | Ep300f/f; Cbpf/f | R-DCKO |
HRGP-Cre+ [46] | Ep300f/f; Cbp+/f | C-Cbp CH |
HRGP-Cre+ | Ep300+/f; Cbpf/f | C-p300 CH |
HRGP-Cre+ | Ep300f/f; Cbpf/f | C-DCKO |
Rho-iCre+ | tm4(ACTB-tdTomato,-EGFP) [47] | R-mT/mG |
HRGP-Cre+ | tm4(ACTB-tdTomato,-EGFP) | C-mT/mG |
Loss of p300 and CBP in rods disrupts retinal structure and function
Hematoxylin-and-eosin (H&E) stained retina sections from four-week-old mice with rod-specific knockout of Ep300 and/or Cbp (see Table 1) were examined for morphological defects. Compared to the Cre-negative (“Cre-neg”, Fig. 1A) and Rho-iCre (“RCre+”, Fig. 1B) controls, single conditional knockout of either Ep300 (“p300KO”, Fig. 1C) or Cbp (“CbpKO”, Fig. 1D) in rods has little effect on retinal morphology. No apparent morphological changes were detected in these retinas up to 30 weeks of age (data not shown). In contrast, knocking out both Ep300 and Cbp together (“R-DCKO”, Fig. 1G&H) severely disrupts lamination of the outer (ONL) and inner (INL) nuclear layers. The ONL forms whorls and rosettes, the cells fail to develop outer segments (OS), and the outer plexiform layer (OPL), where ONL and INL neurons form synaptic connections, is irregular and thin. INL cells positive for the rod on-bipolar cell marker Protein Kinase Cα (PKCα Fig. 1H) that also express P300 (Fig. 1K&L) extend into the ONL in the spaces between the rosettes. The total width of this disorganized retina is about 30–50% greater than control retina sections (data not shown). Cones in R-DCKO retinas are scattered throughout the ONL, often in the middle of rosettes of p300/CBP-negative cells (Fig. 1L, red cells), instead of evenly distributed in the outer part of the ONL as in normal retinas (Supplemental Fig. S2A&B). Interestingly, the defects seen in R-DCKO retinas are mostly prevented in compound heterozygous mice carrying one wild-type (WT) allele of either Ep300 (“p300 CH”, Fig. 1E) or Cbp (“Cbp CH”, Fig. 1F), suggesting that p300 and CBP play redundant but critical roles in developing and maintaining appropriate retina architecture. However, in contrast to the essentially normal appearance of the p300 CH retina, Cbp CH retinas show slight irregularities in the ONL and OPL within 1000 µm of the optic nerve head (Fig. 1F).
Electroretinogram (ERG) testing at 4 weeks of age revealed functional deficits consistent with the morphological changes. Single conditional knockout mice had essentially normal ERGs (Fig. 1M, N&O, top graphs, green & blue vs. black lines). R-DCKO mice had very little rod-driven response (Fig. 1M&N, bottom graphs, red lines), and cone ERG responses were significantly smaller than those of Cre-negative littermates (Fig. 1O, bottom graph, red vs. black line). Compound heterozygote mice with one WT Ep300 allele (p300 CH) showed essentially normal rod and cone function (Fig. 1M, N&O, bottom panels, orange line). In contrast, mice with a single WT copy of Cbp (Cbp CH) showed slight but significant decreases in rod-driven a-wave and b-wave amplitudes (Fig. 1M&N, bottom panels, pink line). Together, the ERG results are consistent with the morphological findings, and suggest that p300 and CBP play mostly overlapping roles in retinal structure and function.
To determine if the structural and functional defects in Ep300/Cbp conditional knockout mice progress over time, retinal morphology and function were reassessed at 8 and 12 weeks of age. Fig. 2 shows that, while R-DCKO mice show no additional changes in retina morphology (Fig. 2D&K vs. Fig. 1G) or rod-driven ERG function (Fig. 2E, F, L&M, red lines, vs Fig. 1M&N, red lines) at either age, cone ERG responses worsened (Fig. 2G&N vs Fig. 1O, red lines), consistent with progressive loss of cones with age (data not shown). The structural and functional defects in R-DCKO retinas persist throughout the life of the animals (Fig. 2 and additional data not shown). Interestingly, ONL morphology of the compound heterozygous Cbp CH mice improved with age: the ONL irregularities near the optic nerve head (Fig. 1F & Fig. 2C) completely resolved by 12 weeks of age (Fig. 2J). However, the rod-driven ERG remained defective in Cbp CH mice (Fig. 2F&M, pink lines). The p300 CH mice also developed decreased rod ERG responses (Fig. 2F&M, orange lines) relative to Cre-negative littermates (black lines) as they aged, despite the normal appearance of their retinas at all ages, and normal rod ERGs at 1 month of age (Fig. 1N). These results suggest that a single copy of either Ep300 or Cbp is insufficient to maintain normal retinal function throughout life.
To determine if the onset of the morphological disruption in R-DCKO and Cbp CH mice correlated with the loss of p300/CBP expression, retinas were examined histologically at P7, P10, P14 and P21 (Fig. 3A). Control and R-DCKO retinas were also examined for p300 immunoreactivity (Fig. 3B). At P7, before morphologic abnormalities appear in R-DCKO retinas, a few ONL cells show decreased p300 staining. At P10, as the number of p300-negative cells increases, irregularities in ONL structure begin to appear in R-DCKO but not compound heterozygote retinas. By P14, whorls and rosettes are seen throughout the R-DCKO ONL, and most cells in this layer have lost p300 (and CBP, data not shown) immunoreactivity. By P21, the only remaining p300-positive cells in the outer retina of R-DCKO also react with antibodies to cone proteins (see Fig. 1L and Supplemental Fig. S2A&B), indicating that they are displaced cone photoreceptors. Thus, the severity and timing of phenotype development directly correlate with the loss of expression of Ep300/Cbp in the conditional knockout retinas. Similar temporal development of the Cbp CH phenotype was also detected: Irregularities are first apparent at P14 (Fig. 3A) and persist through 8 weeks of age (Fig. 2C), but resolve by 12 weeks (Fig. 2J).
To determine whether cell death contributes to the structural and functional defects, we stained for cells containing fragmented DNA using the “Terminal Deoxynucleotidyl Transferase dUTP Nick End Labeling” (TUNEL) assay [48]. When TUNEL-positive cells in retina sections from P10, P14, and P32 animals were counted (Fig. 3C), the only significant difference from age-matched Cre-negative control eyes was seen in Cbp CH eyes at P32 (pink bar indicated by arrow in Fig. 3C). As shown in Fig. 3D, TUNEL-positive cells in these eyes were frequently found near the abnormal ONL folds, suggesting that these morphologic abnormalities may be resolved through cell death, as has been reported in the Nr2e3-null mutant mouse rd7 [49]. R-DCKO retinas showed very few TUNEL-positive cells at this age (Fig. 3E). Immunostaining for histone H2A.X (Supplemental Fig. S3A), which recognizes double-stranded DNA breaks, supported this finding. Cell proliferation in the retina is mostly complete by the time Rho-iCre expression begins at P5, but re-entry of CKO cells into the cell cycle could contribute to the abnormal morphology of R-DCKO retinas. To investigate whether this occurs, P7 – P14 retinal sections were stained for proliferation markers Ki67 and phosphorylated histone H3 (Supplemental Fig. S3B shows P14, Supplemental Fig. S3C shows P10). Very few cells were positive for either marker in sections from any genotype at any of these ages, and no significant differences were found between Cre-negative and R-DCKO sections. R-DCKO outer retina cells also did not show increases in markers associated with other mature retina cell types (Supplemental Fig. S2) or retinal progenitors (Supplemental Fig. S4). These results suggest that conditional knockout of p300/CBP in differentiated rods does not increase either cell death or proliferation, or lead to a change in cell fate.
Loss of p300 and CBP in rods alters the characteristic nuclear chromatin organization
Rod photoreceptors in the mouse retina have a unique chromatin organization: After birth but before the eyes open, dense, gene-poor heterochromatin usually found at the nuclear periphery in other cell types is positioned at the center of rod cell nuclei, surrounded by a peripheral ring of euchromatin (Fig. 4A, “Cre neg”) enriched for transcriptionally active DNA [44] [50]. In R-DCKO mice, the rods begin to develop this unique chromatin organization around P10, but the process reverses after P12 (data not shown). Most cells in the adult R-DCKO ONL show dense heterochromatin in a thin ring at the nuclear periphery and one or two small condensations in the inner nucleus (Fig. 4A, “R-DCKO”), a chromatin distribution pattern more similar to inner nuclear layer cells than to wild-type rods. Retinas from both compound heterozygote genotypes also show increases in electron-lucent euchromatin, but retain large dense heterochromatin domains in the center of their nuclei (Fig. 4A, “p300 CH” and “Cbp CH”). Quantification of the percentage of total nuclear area taken up by heterochromatin (Fig. 4B) shows that heterochromatin is decreased relative to euchromatin in these CKO retinas. These results suggest that Ep300/Cbp are involved in maintaining the characteristic nuclear chromatin organization in mouse rods.
Acetylated and methylated histone marks associated with gene activation and repression define concentric chromatin domains in wild-type mouse rod photoreceptor nuclei [49]. “Repressive” marks (trimethylation of H3K27, H3K9 and H4K20) are typically localized to heterochromatin in the dense nuclear core. “Activation” marks associated with euchromatin (H3 and H4 acetylation and H3K4 tri-methylation) are localized to the nuclear periphery, where transcription takes place. We therefore compared the distribution of two repressive histone marks: H3K9me3 (Fig. 4C) and H3K27me3 (Fig. 4D), and two activation marks: AcH3 (Fig. 4E) and AcH4 (Fig. 4F), in Cre-negative and R-DCKO retinas. The two repressive marks are redistributed in R-DCKO rod nuclei: unlike the large area of intense staining in the center of control rod nuclei, R-DCKO retinas show smaller, fragmented areas of intense reactivity with a weak ring of stain at the nuclear periphery (Fig. 4C&D). The two activation marks, which are found in a ring near the nuclear periphery in control rods, form scattered speckles in the middle of R-DCKO ONL cell nuclei (Fig. 4E&F). Thus, the nuclear organization of histone-marked territories is altered in R-DCKO rods, consistent with the heterochromatin and euchromatin redistribution seen by ultrastructural analysis.
To determine whether this altered nuclear organization reflects changes in global levels of acetylated histone H3 and H4, the products of p300/CBP and other acetyltransferases, quantitative Western blots were performed using the Li-Cor Odyssey Infrared Imager to compare AcH3 and AcH4 levels of R-DCKO vs. control retinas (Fig. 4G&H). No significant changes in total retinal AcH3 and AcH4 levels were detected in 4-week old R-DCKO vs. control retinas, as measured by fluorescent band intensities normalized to total histone H2B or H3 bands (Fig. 4H). Similar results were obtained at P14, P20 and 6 weeks (data not shown). Since rods constitute 70% of cells in the mouse retina, these results, together with the similar overall intensity of AcH3/AcH4 immunostaining of R-DCKO vs control retinas, suggest that p300/CBP depletion does not alter total levels of acetylated histone H3 and H4, although their distribution within the nucleus is affected.
Loss of p300 and CBP in rods alters gene transcription and promoter-bound acetylated H3/H4
To investigate global gene expression changes underlying the morphological and functional defects in R-DCKO eyes, we performed microarray analysis on P14 whole retina samples. P14 was chosen because 1) CRE-mediated p300/CBP depletion is complete at this age (Fig. 3B); 2) previous findings showed that CRX-dependent p300/CBP recruitment to CRX target genes reaches a peak at this age [5]; and 3) secondary effects on bipolar, horizontal, and Mueller cell gene expression should be minimal this early. Three samples representing each genotype were tested in triplicate on Illumina BeadArray Mouse WG-6 V2 chips. Each microarray sample contained pooled RNA from a male and female littermate of the same genotype, to control for any sex-related differences. The raw datasets are available through the NCBI GEO website (http://www.ncbi.nlm.nih.gov/geo/, accession number GSE47699). Results were examined using Illumina GenomeStudio V1.6 software, and genes with differential scores greater than 13.0 (P<0.05) vs the Cre-negative control group were considered differentially expressed. Dramatic changes in expression were seen in the R-DCKO retinas: 520 genes were differentially down-regulated (Supplemental Table S2) and 579 were up-regulated (Supplemental Table S3). The wide variety of functions affected (Fig. 5A) indicates that p300 and CBP are involved in expression of many genes required for general cell maintenance as well as photoreceptor-specific structures and functions.
Many of the photoreceptor genes down-regulated in R-DCKO retinas appear in published lists of retina disease genes (https://sph.uth.edu/RetNet/home.htm), and genes affected in retinas of mice with knockout of the earliest expressed photoreceptor regulatory gene, Crx [51] [52] [53]. Figure 5B shows a Venn diagram summarizing the overlap between these gene sets and the 62 photoreceptor-related genes decreased in R-DCKO retinas. Ep300/Cbp conditional knockout decreased expression of 45 genes associated with retinal diseases (Supplemental Table S4). Interestingly, three additional retinal disease genes expressed in rods were up-regulated in R-DCKO retinas: “Topoisomerase I Binding, Arginine/serine-rich” (Topors, 147% of control levels), “Transmembrane Protein 126A” (Tmem126a, 160%), and “Retinitis Pigmentosa 9” (Rp9, 232%). Among the genes down-regulated in R-DCKO retinas, 101 were also reported decreased in Crx−/− retinas in other studies [51] [52] [53] (Supplemental Table S5). These genes are likely components of the CRX/NRL pathway in rods, consistent with p300/CBP acting as a coactivator. We were not surprised that cone-specific CRX downstream targets, such as cone opsins, transducin (Gnat2) and phosphodiesterase (Pde6c), were not affected in Rho-iCre conditional knockout mice, since Crx functions in both rods and cones but Rho-iCre only drives Ep300/Cbp conditional knockout in rods.
Quantitative RT-PCR (qRT-PCR) and immunohistochemistry (IHC) were used to confirm decreases in expression of a subset of rod photoreceptor genes (Fig. 5C–F and Supplemental Fig. S5A). AcH3/AcH4 levels on the promoter regions of these genes were also investigated by quantitative chromatin immunoprecipitation (qChIP) (Fig. 5C–F and Supplemental Fig. S5B). Importantly, in R-DCKO retinas, both microarray and qRT-PCR assays revealed drastically reduced expression of Nrl, the rod-specific transcription factor essential for rod identity (23% and 12% of control expression levels, respectively) and Crx, the pan rod/cone transcription factor (31% and 29% of controls) (Fig. 5C&D, red bars in qRT-PCR graphs, and Supplemental Tables S2, S4 and S5). IHC showed that the defect in Crx expression is localized to p300/CBP-negative cells (Fig. 5D far left panel and data not shown), indicating a cell-autonomous effect of Ep300/Cbp null mutations on Crx transcription in target cells. In R-DCKO retinas transcription of Rhodopsin (Rho, Fig. 5E, red bar in center graph) and Rod transducin (Gnat1, Fig. 5F) was abolished (6% and 4% of control levels), consistent with the microarray results (8% and 15% of control levels). Immunostaining also confirmed little expression of RHO or rod transducin in the R-DCKO outer retina (Fig. 5E&F, left panels). Marked decreases in transcription of other rod genes Pde6b (12% by qRT-PCR vs 14% by microarray), and Rbp3 (31% by qRT-PCR vs 25% by microarray) were also confirmed (Supplemental Fig. S5A, red bars). Cone opsin (Opn1MW and Opn1SW) transcription was not affected (Supplemental Fig. S5A). In contrast to the rod-to-cone fate switch seen in Nrl−/− retinas [54] [55], p300/CBP-negative cells in R-DCKO retinas do not express cone markers, including cone arrestin (Fig. 1L) or cone opsins (Supplemental Fig. S2A&B).
Chromatin immunoprecipitation assays revealed that knockout of both Ep300 and Cbp in rods completely removed AcH3 and AcH4 marks from the promoter of Nrl, Crx, Rho, Gnat1 (Fig. 5C–F, right graphs, red bars), and Pde6b (Fig. S5C). These results are consistent with the lack of expression of these genes. AcH3 and AcH4 marks were moderately decreased on the cone opsin gene promoters in R-DCKO retina (Fig. S5B&C) despite the normal expression levels of these genes. The Rbp3 promoter, which is expressed in both rods and cones, showed only slightly decreased levels of acetylated histones, comparable to levels on the promoter of the bipolar cell gene “Metabotropic glutamate receptor type 6” (Grm6, Fig. S5B), despite the decrease in transcription seen both by microarray (25% of controls, Supplemental Tables S2, S4, S5) and qRT-PCR (31% of controls, Supplemental Fig. S5A). These results suggest that AcH3/AcH4 level changes are gene- and cell-type specific.
In compound heterozygous mice (Cbp CH or p300 CH), one copy of either Ep300 or Cbp was sufficient to preserve expression of both Nrl and Crx transcription factors (Fig. 5C&D, center graphs, pink and orange bars vs red), consistent with the higher AcH3 and AcH4 levels seen on the Nrl and Crx promoters in these retinas (Fig. 5C&D, right graphs, pink and orange bars vs. red). Expression of rod genes and promoter AcH3/AcH4 levels was partially restored (Fig. 5C–F and Supplemental Fig. S5), with Ep300 (orange bars) more effective than Cbp (pink bars), consistent with the morphological and functional data. As expected, cone gene transcription was not affected in compound heterozygous mice (Supplemental Fig. S5A), although Opn1MW promoter AcH3/AcH4 levels were still moderately decreased (Supplemental Fig. S5B, orange and pink bars vs. blue). Taken together, the results of all expression assays suggest that p300/CBP keep chromatin containing rod transcription factors and structural genes in a transcriptionally active configuration (marked by AcH3/AcH4), to maintain rod cells in their terminally differentiated state.
Loss of p300/CBP in cones causes defects in cone gene expression, structure and function
The role of p300 and CBP in differentiated cones was examined using the cone-specific Cre line HRGP-Cre (CCre). Unlike knockout in rods, knockout of both Ep300 and Cbp in cones (C-DCKO) did not lead to gross abnormalities in retinal morphology (Fig. 6D vs. 6A). However, the cone nuclei appeared enlarged and abnormally shaped (arrowheads and insets in Fig. 6D), and occasional similar cells are seen in the inner ONL or outer plexiform layer. These abnormal cones were not seen in the retinas of compound heterozygous mice carrying one normal allele of either Ep300 (Fig. 6B “C-p300 CH”) or Cbp (Fig. 6C, “C-Cbp CH”). Furthermore, the cones in the double knockout retina showed defective outer segments marked by peanut agglutinin (Fig. 6G). The expression of the cone markers cone arrestin (CARR, Fig. 6E), S-opsin (Fig. 6F), and cone transducin-alpha (Fig. 6H) was markedly decreased. Consistent with these morphological and gene expression defects, C-DCKO mice completely lack cone ERG responses (Fig. 6K “light b-waves”, red vs. blue lines) without significantly affecting rod ERG responses (Fig. 6I “dark a-waves” graphs). The decrease in dark-adapted b-waves at high stimulus intensities (Fig. 6J) provides further evidence of a cone functional defect, since cones contribute to dark-adapted ERG responses to bright flashes. This cone ERG defect was less pronounced in mice with one normal copy of either Ep300 (Fig. 6K, orange line) or Cbp (Fig. 6K, pink line). Thus, p300 and CBP also play a redundant role in maintaining cone gene expression, structure and function.
Discussion
p300 and CBP play overlapping and distinct roles in establishing photoreceptor structure and function and maintaining their cell identity
During postnatal mouse retinal development between P10 and P21, post-mitotic opsin-positive photoreceptors undergo terminal differentiation and maturation. At the cellular level, they elaborate outer segments containing the phototransduction machinery, and make synaptic connections to inner neurons. At the molecular level, expression of many photoreceptor genes increases to adult levels during this time [5]. All these terminal differentiation processes depend on continuing expression of Ep300 and/or Cbp. Although conditional knockout of both genes causes severe defects, one wild-type allele of either Ep300 or Cbp can mostly prevent these defects, indicating that p300 and CBP are redundant for this critical role. These results agree with findings from a study of postmitotic mouse brain neurons [56], that loss of either p300 or CBP alone does not affect cell viability or cause severe defects. However, these investigators found modest memory and transcriptional deficits after brain-specific knockout of either Ep300 or Cbp, whereas we did not observe any functional, structural and molecular consequences of knocking out either gene alone in retinal photoreceptor neurons. This could be due to the late expression of Opsin-driven Cre in already differentiated photoreceptors, which limits our ability to investigate the role of Ep300/Cbp in early photoreceptor differentiation from postmitotic precursors. Future studies using an early photoreceptor gene promoter to drive Cre expression will address whether either p300 or CBP alone is required for early photoreceptor development and if they play distinct functions in this process. Such studies are important for understanding the rod/cone dystrophy phenotypes of Rubinstein-Taybi syndrome (RSTS) [40], a disease associated with heterozygous CBP [33] or Ep300 mutations [34]. However, the present study has provided some hints of distinct roles for p300 and CBP in photoreceptor terminal differentiation: Although one copy of either Ep300 or Cbp essentially prevents the R-DCKO phenotype, mice expressing a single WT copy of Cbp show slight defects in rod morphology, function and gene expression, suggesting that p300 may have functions in photoreceptor maturation and maintenance that CBP cannot fulfill. In this regard, a recent study using a glioma-derived cell line [57] showed that p300 and CBP each binds some unique target gene promoters in addition to the numerous targets they share. Even when both factors bind and regulate the same gene in a given cell type, such as αA-crystallin in newborn mouse lens fibrocytes, they have been found differentially distributed along the locus [58], suggesting distinct regulatory mechanisms. Our own studies in Crx−/− mouse retina show that Opsin promoter occupancy by CBP, but not p300, requires Crx [5]. Thus, p300 may have a wider range of CRX-independent photoreceptor target genes than CBP, supporting distinct roles for these two coactivators in photoreceptor gene activation.
Cellular mechanisms underlying the phenotypes of Ep300/Cbp conditional knockouts
Cell autonomous and non-autonomous effects
The severely disrupted retinal morphology and photoreceptor function in rod-specific knockout of CBP/p300 (R-DCKO) suggest the involvement of both cell autonomous and non-autonomous mechanisms. The cone dysfunction and gene expression defects are likely secondary to ONL disorganization. Cone cell death often occurs in retinas with rod degeneration disorders. It is known that support provided by RPE and soluble growth factors secreted by rods play important roles for cone integrity and survival. In R-DCKO retinas, many cones are displaced in the center of whorls and rosettes where they are not in contact with the RPE, which prevents them from getting metabolic support from the RPE. The p300/CBP-negative “rods” likely fail to express protective growth factors/cytokines as well as other rod-specific genes. At least one such factor, rod-derived cone viability factor [59] encoded by the gene nucleoredoxin-like 2 (Nxnl2) [60], is down-regulated (11% of control levels) in R-DCKO retinas (Supplemental Tables S2 & S5). Secondary, cell non-autonomous defects may also account for R-DCKO's invasive inner nuclear layer (INL) and thin/irregular outer plexiform layer (OPL), where synapses between photoreceptors and inner retina neurons are located. Inner retina abnormalities and remodeling are often seen in late stages of photoreceptor degeneration diseases [61], including the Crx−/− mouse model. In contrast, the cone-specific knockout C-DCKO essentially shows cell autonomous defects in cones without affecting rod structure and function. It remains to be determined whether any changes occur in inner neurons of the C-DCKO retina.
Cellular basis for whorls and rosettes in R-DCKO
Abnormal retinal folds are often seen in mouse models where the rods undergo a cell fate switch to cones (Nrl−/− or Nr2e3rd7/rd7) [49] [54] [62], or which compromise the retinal outer limiting membrane (OLM), composed of adherens junctions between photoreceptors and Müller glia (the naturally occurring Crumbs 1 mutation Crb1rd8/rd8, or knockout of the LIM homeobox protein Lhx2) [63] [64]. The severe retinal “whorls and rosettes” phenotype seen in R-DCKO is likely contributed by both mechanisms: 1) Nrl expression is decreased in R-DCKO rods, leading to the loss of rod identity and increase in nuclear volume; 2) OLM abnormalities, which could be caused by defective adherens junctions or changes in cell polarity. Microarray showed that expression of both “Crumbs 1” (Crb1) and an associated protein “membrane protein, palmitoylated 4” (Mpp4) [65] are decreased (53% and 14% of controls, respectively). The above two mechanisms are not mutually exclusive, as a recent study has shown that OLM defects are associated with rosette development in the Nrl−/− mouse retina [66]. Finally, the retinas of Sca7 mice also develop ONL whorls and rosettes with changes in the rod chromatin pattern [67], similar to those we see in our compound heterozygotes. Sca7 mice have defects in the GCN5-containing STAGA transcriptional activation promoting complex. This implicates decreased lysine acetyltransferase and/or chromatin remodeling activity as an underlying cause of whorls and rosettes.
Cell survival vs. death
To our surprise, R-DCKO photoreceptors and inner retina neurons do not die but survive for a long period (at least through 30 weeks of age) despite down-regulation of many photoreceptor genes, normally a trigger for photoreceptor degeneration. R-DCKO cells do not re-enter the cell cycle, but remain in a quiescent state. The mechanism for this phenotype is unclear. This does not appear to be a form of senescence, since the microarray analysis showed no changes in expression of the senescence-associated “Cyclin-dependent kinase inhibitor” genes CDKN1a/p21, CDKN2a/p16/INK4A, or their downstream targets [68] in the R-DCKO retinas. Since p300 and CBP are required to activate transcription of lineage-specification-associated genes for cell fate switching [5] [69] as well as genes associated with cell proliferation and survival [70], one possible explanation is that the global and severe changes in gene expression in R-DCKO strand the cells in a transitional state, unable to either progress along an alternative lineage, regress, or die. Supporting this hypothesis, 4-week-old Cbp CH compound heterozygous mice did show increased cell death associated with minor ONL folds (Fig. 3C&D), suggesting that programmed cell death is induced in p300/CBP-deficient photoreceptors if minimal CBP protein is available. A search of the R-DCKO microarray data revealed up-regulation of 18 genes involved in cell death pathways, including: “BCL2-interacting killer” (Bik, 1873% of controls), Caspase 6 (246%), “Bcl2-associated X protein” (Bax, 231%), “apoptotic peptidase activating factor 1” (Apaf1, 189%), “CASP8 and FADD-like apoptosis regulator” (Cflar, 163%), and “BCL2-associated agonist of cell death” (Bad, 150%) (Supplemental Table S3). BIK initiates apoptotic responses to genotoxic stress or disruption of host cell protein synthesis in processes like viral infections or treatment with proteasomal or protein synthesis inhibitors. It activates BAX via Ca2+ release from intracellular stores, leading to activation of the mitochondrial apoptotic pathway, and has also been implicated in an autophagy-mediated cell death pathway [71]. Thus, the high level of Bik activation likely represents an attempted response to the metabolic disruption caused by loss of the two general transcription coactivators. However, at this point we can only speculate that the failure of R-DCKO cells to die results from their failure to synthesize or activate late-stage effectors such as Caspase 9/3 or autophagic mediators, since these were not present among the up-regulated genes detected by microarray.
The identity of p300/CBP-negative cells
Gene expression and immunohistochemistry studies have shown that p300/CBP-negative ONL cells in R-DCKO have completely lost their photoreceptor identity. The true identity of these cells is unknown, but they appear to be undifferentiated cells that do not express any neuronal or glial progenitor markers. At the ultra-structural level, these cells still have neurites extending from their cell bodies (data not shown), suggesting their neuronal origin. This phenotype clearly demonstrates the requirement of p300/CBP in maintaining differentiated photoreceptors.
Molecular mechanisms for transcriptional dysregulation in Ep300/Cbp conditional knockouts
Our results showed that knockout of Ep300/Cbp in rods or cones causes severe transcription defects in many genes expressed in photoreceptors, leading to a much more severe phenotype than is seen after knockout of any single photoreceptor transcription factor. This is understandable, since p300/CBP are cofactors for a wide variety of general as well as cell-type specific transcription factors. However, a substantial subset of the genes down-regulated in the microarray assay are involved in photoreceptor structure and function. Furthermore, conditional knockout of Ep300/Cbp leads to loss of photoreceptor identity. Our findings emphasize the need for continuing expression of these photoreceptor genes to maintain functional photoreceptors, and the role played by Ep300/Cbp in this expression.
This study has provided evidence of at least three mechanisms that directly underlie the transcriptional dysregulation in DCKO photoreceptors.
Decreased expression of key photoreceptor transcription factors
Transcription factors CRX, NRL and NR2E3 specify rod photoreceptor cell fate by regulating many photoreceptor genes. The expression of all three factors is lost from R-DCKO retinas, but preserved in retinas with a single normal copy of either Ep300 or Cbp, suggesting that p300 and CBP are redundant in promoting the expression of these key regulator genes. Although severe transcription defects are expected in cells directed to the photoreceptor lineage that lack these transcription factors, the loss of coactivator/HAT function likely also contributes to the wide-spread transcription dysregulation seen by microarray analysis. Furthermore, transcription of photoreceptor genes remains defective to various degrees even when photoreceptor transcription factor expression is restored in the presence of one copy of Ep300 or Cbp. Future experiments to restore the expression of CRX and NRL in R-DCKO retinas will separate the contribution made by the lack of transcription factors from the direct results of coactivator deficiency. Furthermore, genetic interaction studies in mice lacking transcription factor and coactivator pairs might help to determine the importance of functional interactions between a specific transcription factor and either coactivator.
Defects in histone acetylation
Quantitative Western blot assays showed that loss of p300 and CBP in rods did not alter the overall levels of acetylated histone H3/H4, suggesting that other factors (HATs or HDACs) are also involved in maintaining acetylated histone levels. However, an important finding is that knockout of p300/CBP selectively affected acetylated histone H3/H4 levels and transcription of all the CRX target genes tested. This raises the question whether loss of p300/CBP causes redistribution of acetylated histone H3/H4 among chromatin regions and gene sets being transcribed. Interestingly, microarray assays detected a similar number of genes that are up-regulated (n = 579) vs. down-regulated (n = 520). The relationship between p300/CBP-dependent histone acetylation and transcription remains to be investigated. Genome-wide ChIP assays on gene association of acetylated histone H3/H4 in the Ep300/Cbp mutant vs control retinas might provide additional information. On the other hand, this relationship is supported by the results from the p300 CH and Cbp CH compound heterozygous mice, where the levels of histone acetylation and target gene transcription are generally correlated. These results are consistent with our previous observations that histone acetylation precedes transcriptional activation of photoreceptor genes during development [5], and strongly support the importance of p300/CBP-mediated histone acetylation in initiating and maintaining photoreceptor gene transcription. It remains to be determined if the HAT catalytic activity of p300/CBP directly accounts for the observed histone acetylation defects, because both factors have additional coactivator functions [14] [35]. They interact with numerous non-HAT and HAT-harboring transcription regulators, including members of the KAT2 family, GCN5-KAT2A and PCAF/KAT2B [19]. GCN5 interacts with CRX indirectly via ataxin-7, a component of the STAGA coactivator complex involved in regulating histone acetylation and transcription of CRX target genes during retinal development [5] and in photoreceptor degeneration associated with Spinocerebellar Ataxia 7 polyglutamine expansion disease [67] [72] [73]. Thus, loss of the action of these HATs could potentially contribute to defective histone acetylation and transcription of photoreceptor genes in Ep300/Cbp knockout mice. In addition, levels of histone acetylation and transcription do not always show a linear relationship for each individual gene. For example, in Cbp CH mice the Crx promoter has less than 50% of normal AcH3/AcH4 levels, but Crx transcription appears normal (Fig. 5D, pink bars), suggesting that the effect of histone acetylation on transcription may depend on gene context. Finally, changes in histone acetylation might affect other histone modifications or higher order chromatin organization, which could also contribute to transcription dysregulation in the Ep300/Cbp knockout mice.
Disruption of normal nuclear chromatin organization
One important finding is that double conditional knockout retinas lose the characteristic densely packed chromatin in rod nuclei, and this phenotype is only partially prevented in p300 CH and Cbp CH compound heterozygous mice. During the late stages of photoreceptor development, mice and other nocturnal mammals reorganize their rod photoreceptor chromatin to minimize light scatter [44]. The condensed, transcription-poor heterochromatin is organized in the central area of the rod nucleus. The less condensed euchromatin containing transcription factors [67], activated RNA polymerase [50], splicing machinery and nascent RNA transcripts [44] are all localized to the nuclear periphery, indicating that this is the site of active gene transcription. The mechanisms responsible for establishing and maintaining this unique nuclear organization are being elucidated. In non-photoreceptor cells, two apparently parallel interactions involving nuclear Lamin A/C or the Lamin B receptor (LBR) anchor heterochromatin enriched in LINE elements to the nuclear periphery [74]. Mouse retinal cells initially use the Lamin B receptor interaction, then as they differentiate switch to the Lamin A/C mechanism, but rod photoreceptors never activate Lamin A/C expression. Loss of Lbr expression correlates with heterochromatin reorganization in normal mouse rods. Although expression of Lbr is not significantly increased in R-DCKO retinas, another receptor for Lamin B, Lmnb2, is upregulated (181% of Cre neg in microarray assays).
The rod transcription factor NRL appears to be involved in the reorganization of mouse rod nuclear chromatin. Mice in which NRL or its upstream activator “Retinoid-related orphan nuclear receptor beta” (Rorb) are knocked out fail to reorganize their heterochromatin, but in Rorb−/− mice expression of an NRL transgene driven by the Crx promoter restores rod nuclear morphology [75]. In addition, the process may involve the Retinoblastoma (RB) family of pocket proteins, which are active in developing mouse rod photoreceptors at the time when nuclear reorganization occurs. Heterochromatin condensation also fails to occur in the absence of RB [76]. The RB protein directs pericentric and telomeric heterochromatin formation [77] as well as recruiting histone deacetylases (HDAC) to active gene promoters to silence transcription (reviewed in [78]). Longworth and Dyson [79] suggest that RB functions as a “master regulator of chromatin structure”; expression of Rb and its mouse homologs Rbl1/p107 and Rbl2/p130 were unaffected in the microarray assays as expected if CBP/p300 are downstream effectors. Since rod nuclear chromatin also decondenses in mice with defects in STAGA complex (containing GCN5) [67], transcription coactivators with histone acetyltransferase (HAT) activity seem to be important for maintaining this chromatin architecture. It is unclear why the loss of coactivator HATs results in rod chromatin decondensation similar to that seen in the absence of RB, a repressor associated with HDACs, but these findings all point to the importance of homeostasis between histone acetylation and deacetylation in rod nuclear chromatin organization. Furthermore, our recent studies have demonstrated that the specific rod transcription factors CRX, NRL and NR2E3, play important roles in higher order chromatin organizations, such as chromosomal loops [80], which may contribute to the rod-specific nuclear architecture. A better understanding of how interactions between specific transcription factors and epigenetic modulators regulate rod nuclear organization will provide new insights into general chromatin regulatory mechanisms and how they relate to transcriptional regulation.
Materials and Methods
Ethics statement
This study was approved by the Animal Studies Committee of Washington University in St. Louis, and performed under Protocols # 20090359 and 20120246 (to SC). Mice were housed in a barrier facility operated and maintained by the Division of Comparative Medicine of Washington University School of Medicine. Experiments were carried out in strict accordance with recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (NIH); the Washington University Policy on the Use of Animals in Research; and the Guidelines for the Use of Animals in Visual Research of the Association for Research in Ophthalmology and Visual Science (http://www.arvo.org/animals/). Every effort was made to minimize the animals' suffering, anxiety, and discomfort.
Reagents
Mouse Lines
Ep300 flox mice [19] were obtained from Dr. Paul K. Brindle of St. Jude Children's Research Hospital, Memphis, TN. Cbp Flox mice [39] were obtained from Dr. Jan van Deursen, The Mayo Clinic, Rochester MN. Rho-iCre mice [45] were provided by Dr. Ching-Kang Jason Chen, Virginia Commonwealth University, Richmond, VA. HGRP-Cre mice [46] were provided by Dr. Yun Zheng Le, University of Oklahoma Health Sciences Center, Oklahoma City, OK. ROSA-mTmG Cre reporter mice (B6.129(Cg)-Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo) [47] were obtained commercially (Jax Mice Stock #007576, The Jackson Lab, Bar Harbor, ME). Mice used in this study were bred and housed in Washington University School of Medicine barrier facilities; the genotypes are listed in Table 1. Genotyping primers are listed in Supplemental Table 1. All mice used were negative for RD1 [81] and RD8 [82] mutations.
Antibodies
Used in these studies are listed in Supplemental Table S7. Rhodamine-conjugated peanut agglutinin (RL-1072) was obtained from Vector Laboratories, Burlingame, CA, and the TUNEL staining kit (S7100) from EMD Millipore, Billerica, MA.
Methods
Electroretinography
At least 6 mice of each genotype were tested for ERG at 4, 6, 8 ,12, 20, 30, 40 and 52 weeks of age. Bilateral flash ERG measurements were performed using a UTAS-E3000 Visual Electrodiagnostic System running EM for Windows (LKC Technologies, Inc., Gaithersburg, MD). Mice were dark-adapted overnight, then anesthetized with 80 mg/kg ketamine and 15 mg/kg xylazine under dim red illumination for electrode placement and testing. Body temperature was maintained at 37±0.5°C with a heating pad controlled by a rectal temperature probe (FHC Inc., Bowdoin, ME). The mouse's head was positioned just inside the opening of the Ganzfeld dome and pupils were dilated with 1.0% atropine sulfate (Bausch & Lomb, Tampa, FL). The recording electrode was a platinum loop 2.0 mm in diameter, positioned in a drop of 1.25% hydroxypropyl methylcellulose (GONAK; Akorn Inc., Buffalo Grove, IL) on the corneal surface of each eye. The reference needle electrode was inserted under the skin at the vertex of the skull. The ground electrode was inserted under the skin of the mouse's back or tail. The stimulus (trial) consisted of a brief, full-field flash (10 µs) either in darkness, or in the presence of dim (30.0 cd/m2) background illumination after 10 minutes adaptation time to the background light. The initiation of the flash was taken as time zero. The response was recorded over 250 ms plus 25 ms of pre-trial baseline. Responses from several trials were averaged (see Supplemental Table S6). The amplitude of the a-wave was measured from the average pre-trial baseline to the most negative point of the average trace, and the b-wave amplitude from that point to the highest positive point, without subtracting oscillatory potentials. The log light intensity (log [cd*s/m2]) was calculated based on the manufacturer's calibrations. The amplitudes (in microvolts) of dark-adapted a- and b-waves and light-adapted b-waves were measured from the lowest point of the raw averaged response trace (occurring prior to 50 ms after the flash) to the subsequent highest point (oscillatory potentials were not subtracted). Responses from at least 6 mice of each genotype were compared for each time point. The distributions of ERG response across genotype groups at different light intensities were described by means and standard deviations. The between-group differences were compared using two-way ANOVA for repeated measurement data to account for potential correlations among readings from the same mice, followed by post-hoc multiple comparisons for differences between each genotype and the control group at each light intensity level. All the tests were two-sided and a p-value of 0.05 or less was taken to indicate statistical significance. The statistical analysis was performed using SAS 9.3 (SAS Institutes, Cary, NC). P-values were adjusted for multiple comparisons by a permutation test using the default parameters provided in the LSMestimate statement in Proc Mixed.
Histology and Immunohistochemistry
Eyes from at least three representative mice from each age and genotype group were examined histologically. Mice were sacrificed by pentobarbital overdose and eyes were dissected, immersion-fixed and corneas removed in 4% paraformaldehyde in phosphate buffered saline (PBS). After overnight incubation in fresh fixative, retinas were dehydrated and paraffin-embedded using a Tissue-Tek VIP tissue processor. Sagittal sections 4 µm thick were cut through the optic nerve head, mounted on poly-lysine-coated slides, air-dried, and either stained with hematoxylin and eosin (H&E) for morphologic assessment or used for immunohistochemistry. Antigen retrieval was performed by treating de-paraffinized sections in 0.1 M citrate buffer, pH 6.0 in a pressure cooker for 3 minutes. Cooled slides were blocked 30 minutes in 20% normal goat serum, incubated overnight at 4°C in primary antibody diluted in PBS; rinsed well, then incubated for one hour at room temperature in secondary antibodies conjugated to Alexa-fluor (Invitrogen) or Cy-dyes (Jackson Immunoresearch) diluted in PBS. For some samples, Draq5 (Cell Signaling Technology, Danvers, MA) for nuclear DNA was added to the secondary incubation mix at 1∶5000. After thorough rinsing, slides were coverslipped using Vectashield hard set mounting medium for fluorescence with (H-1500) or without (H-1000) DAPI (Vector Laboratories, Burlingame, CA). Sections were examined and photographed using an Olympus BX51 fluorescence microscope fitted with a Spot RT3 cooled CCD camera (Diagnostic Instruments, Inc). Confocal microscopy was performed on an Olympus Fluo-view FV1000 confocal microscope.
Electron microscopy
Eyecups were fixed by immersion for 12–24 hrs in 2% paraformaldehyde/3% glutaraldehyde in 0.1 M phosphate buffer (pH 7.35), post-fixed in 1% osmium tetroxide for 1 hour and stained en bloc with 1% uranyl acetate in 0.1 M acetate buffer for 1 hr. Blocks were then dehydrated in a graded series of acetones and embedded in Araldite 6005/EMbed 812 resin (Electron Microscopy Sciences). Semi-thin sections (0.5–1 µm) were cut through the entire retina at the level of the optic nerve and stained with toluidine blue. Ultra-thin sections were taken from a 600–800 µm length of retina adjacent to the optic nerve, post-stained with uranyl acetate and lead citrate, viewed on a Hitachi H7500 electron microscope and documented in digital images. For the 5 largest nuclear profiles in each of 10 micrographs of ONL cell bodies from each genotype, total nuclear area and the amount of dense heterochromatin as a percentage of total nuclear area was measured using NIH “Image J” software. For each genotype, the mean and standard deviation was calculated, and compared to values for Cre negative controls using paired Student's t-test.
Nuclear extraction and western blot analysis
The histone extraction protocol used is a modification of the protocol of Shechter et al. [83]. Briefly, retinas were dissected, washed in PBS with proteases (“cOmplete mini” tablets, Roche 11 836 153 001), and incubated 30 minutes at 4°C in hypotonic lysis buffer (10 mM Tris buffer, pH 8.0, with 1.0 mM KCl, 1.5 mM MgCl2, 1 mM DTT, 0.003 mM Trichostatin A and protease inhibitors including 2 mM PMSF. Nuclei were concentrated by centrifugation at 10,000xG for 10 minutes, then lysed by incubating overnight at 4°C in 0.4 N H2SO4. Histones were precipitated from the supernate with trifluoroacetic acid, washed twice with chilled acetone to remove the acid, air-dried, resuspended in deionized, distilled water and quantified on a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). Samples containing 1.0 µg protein were separated on a 17% SDS-PAGE gel (mini-protean TGX pre-cast gels, BioRad), blotted to nitrocellulose using a Transblot Turbo semi-dry transfer system (BioRad), and stained using Li-Cor Odyssey blocking reagent and secondary antibodies (Li-Cor, Lincoln, NE). Blots were imaged on a Li-Cor Odyssey Classic system and analyzed using Image Studio software.
Microarray
Retinas were removed from 3 male and 3 female P14 mice of each genotype, stored in RNAlater (Qiagen), and extracted using the RNeasy kit (Qiagen). Purified RNA was quantified on the NanoDrop and submitted to the Washington University Genome Technology Access Center for quality assessment with the Agilent Technologies 2100 Bioanalyzer “Lab-on-a-chip” system (Agilent Technologies, Santa Clara, CA). Equal amounts of high-quality (RIN score >8.4) RNA samples from one male and one female littermate were pooled for microarray assay on Illumina BeadArray Mouse WG-6 V2 chips (Illumina, San Diego, CA). The raw microarray data were submitted to NCBI GEO (accession number GSE47699). The results were examined using Illumina Genome Studio V1.6 software. Differential expression analysis (Direct hyb-differential expression) was performed using Average normalization and the Illumina custom error model with Benjamini and Hochberg False Discovery Rate (FDR). Genes with differential scores greater than 13.0 between R-DCKO samples and cre-neg littermate control samples (corresponding to P<0.05) are listed in Supplemental Tables 2 (down-regulated in R-DCKO) and 3 (up-regulated in R-DCKO). Cell process categories were determined by searching NCBI GENE (http://www.ncbi.nlm.nih.gov/gene), the Mouse Genome Informatics database (http://www.informatics.jax.org/), Sigma-Aldrich's “My Gene” search tool (http://www.sigmaaldrich.com/catalog/genes/), and Ingenuity Systems (http://www.ingenuity.com/).
Chromatin Immunoprecipitation (ChIP)
Was performed as previously described [84] [85]. Basically, 6 retinas per sample were dissected and chromatin was cross-linked with 1% formaldehyde in PBS for one minute at room temperature. After cell lysis and chromatin fragmentation by sonication, chromatin fragments were immunoprecipitated with antibodies against acetyl-histone H3 or acetyl-histone H4 bound to Protein A beads (GE Healthcare Life Sciences, Piscataway, NJ). After extensive washing, the immunoprecipitated chromatin was eluted with 50 mM NaHCO3/1% SDS, heated to 67°C to reverse the cross-links, the DNA purified by ethanol precipitation and analyzed by PCR with gene-specific primers (see references [5] [84] and [85] for sequences).
qRT-PCR and qChIP
Were performed as previously described [5] [86], in accordance with MIQE guidelines [87]. Primers were designed using MacVector software (MacVector, Inc., Cary, NC). RT-PCR were designed so that the product crosses at least one intron to prevent amplification of any residual genomic DNA. Optimal annealing temperatures and linearity of primer reactions were validated using dilutions of cDNA from control retinas, and primer pairs were only used if reaction efficiency fell between 90–110% and r2>0.980 [88]. Amplification of a single species was confirmed by melt curve analysis and agarose gel electrophoresis.
For qRT-PCR, RNA was extracted from two retinas per sample (∼30 mg tissue) using PerfectPure RNA cell & tissue extraction kit (5-Prime Inc., Gaithersburg, MD) and quantified on the NanoDrop. cDNA was synthesized from 1.0 µg RNA with oligo-dT primers, using the Transcriptor First Strand cDNA Synthesis Kit (Roche 04 379 012 001) according to the manufacturer's directions.
For both qRT-PCR and qChIP, 10 µl reactions were set up in triplicate in 96-well low-profile frosted PCR plates (Midsci, St. Louis, MO), with 2 µM primers (see references [5] [84] [85] [86] for sequences), using SYBR Green JumpStart Readymix (Sigma, St. Louis, MO), and run on a BioRad CFX thermocycler. The test protocol consists of 40 cycles of two-step amplification followed by melt curve analysis. For unknowns, only Cq values that fell within the linear range determined for each primer pair were used; samples giving results outside this range were diluted appropriately and re-tested. Relative expression levels were normalized to three reference genes (ß-Actin [Actb], Glyceraldheyde-3-phosphate dehydrogenase, [GAPDH] and Ubiquitin B [UBB]), which were determined to be highly stable, using qbasePLUS software (BioGazelle NV, Zwijnaarde, Belgium). The mean value and standard deviation (STDEV) were calculated, and statistical significance (p<0.05) was determined using unpaired two-tailed Student's t-test.
Supporting Information
Acknowledgments
The authors wish to thank Dr. Jan van Deursen and Dr. Paul K. Brindle for providing Cbp flox and Ep300 flox mouse lines, Dr. Ching-Kang Jason Chen and Dr. Yun Zheng Le for providing Rho-iCre and HGRP-Cre mouse lines. We also thank the Genome Technology Access Center for help with genomic analysis, and Nick Tran and Philip Ruzycki for help interpreting the microarray data; Julie Huecker and Dr. Mae O. Gordon of the Vision Research Coordinating Center at Washington University School of Medicine for statistical analysis of ERG data; Belinda McMahan, Frank Schottler, Hui Wang, Lili Yu, Mingyan Yang and Winnie Long for technical assistance; and Chen Lab members for suggestions and critical review of the manuscript.
Funding Statement
This work was supported by the National Institutes of Health (NIH) [grant numbers EY012543 to SC and EY02687 to WU-DOVS], a Lew Wasserman Merit Award (to SC) and unrestricted funds (to WU-DOVS) from Research to Prevent Blindness. For use of the electron microscope: the Research Center for Auditory and Vestibular Studies is supported by the National Institutes of Health NIDCD Grant P30DC04665 to the Department of Otolaryngology. For genomic analysis: the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine is partially supported by the National Institutes of Health [National Cancer Institute Cancer Center Support grant number P30 CA91842 to the Siteman Cancer Center; National Center for Research Resources (NCRR) ICTS/CTSA grant number UL1RR024992; and the NIH Roadmap for Medical Research]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Dowling JE (1987) The retina: an approachable part of the brain. Cambridge, MA: The Belknap Press of Harvard University Press. 282 p.
- 2.Rodieck RW (1998) The first steps in seeing. Sunderland, MA: Sinauer Associates, Inc. 562 p.
- 3. Hennig AK, Peng GH, Chen S (2008) Regulation of photoreceptor gene expression by Crx-associated transcription factor network. Brain Res 1192: 114–133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Swaroop A, Kim D, Forrest D (2010) Transcriptional regulation of photoreceptor development and homeostasis in the mammalian retina. Nat Rev Neurosci 11: 563–576. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Peng GH, Chen S (2007) Crx activates opsin transcription by recruiting HAT-containing co-activators and promoting histone acetylation. Hum Mol Genet 16: 3433–3452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR, et al. (1993) Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365: 855–859. [DOI] [PubMed] [Google Scholar]
- 7. Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, et al. (1994) Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev 15: 869–884. [DOI] [PubMed] [Google Scholar]
- 8. Martinez E, Palhan VB, Tjernberg A, Lymar ES, Gamper AM, et al. (2001) Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo. Mol Cell Biol 21: 6782–6795. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Li B, Carey M, Workman JL (2007) The role of chromatin during transcription. Cell 128: 707–719. [DOI] [PubMed] [Google Scholar]
- 10. Kouzarides T (2007) Chromatin modifications and their function. Cell 128: 693–705. [DOI] [PubMed] [Google Scholar]
- 11. Jin Q, Yu LR, Wang L, Zhang Z, Kasper LH, et al. (2011) Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation. Embo J 30: 249–262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Cvekl A, Mitton KP (2010) Epigenetic regulatory mechanisms in vertebrate eye development and disease. Heredity 105: 135–151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Bedford DC, Kasper LH, Fukuyama T, Brindle PK (2010) Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases. Epigenetics 5: 9–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Bedford DC, Brindle PK (2012) Is histone acetylation the most important physiological function of Cbp and p300? Aging 4: 247–255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953–959. [DOI] [PubMed] [Google Scholar]
- 16. Bannister AJ, Kouzarides T (1996) The CBP co-activator is a histone acetyltransferase. Nature 384: 641–643. [DOI] [PubMed] [Google Scholar]
- 17. McManus KJ, Hendzel MJ (2003) Quantitative analysis of Cbp- and p300-induced histone acetylations in vivo using native chromatin. Mol Cell Biol 23: 7611–7627. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Das C, Lucia MS, Hansen KC, Tyler JK (2009) CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 459: 113–117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Kasper LH, Fukuyama T, Biesen MA, Boussouar F, Tong C, et al. (2006) Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development. Mol Cell Biol 26: 789–809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Yamauchi T, Oike Y, Kamon J, Waki H, Komeda K, et al. (2002) Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice. Nature Genet 30: 221–226. [DOI] [PubMed] [Google Scholar]
- 21. Turnell AS, Stewart GS, Grand RJ, Rookes SM, Martin A, et al. (2005) The APC/C and CBP/p300 cooperate to regulate transcription and cell-cycle progression. Nature 438: 690–695. [DOI] [PubMed] [Google Scholar]
- 22. Kasper LH, Boussouar F, Ney PA, Jackson CW, Rehg J, et al. (2002) A transcription factor binding surface of coactivator p300 is required for haematopoiesis. Nature 419: 738–743. [DOI] [PubMed] [Google Scholar]
- 23. Korzus E, Rosenfeld MG, Mayford M (2004) CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 42: 961–972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Wood MA, Attner MA, Oliveira AM, Brindle PK, Abel T (2006) A transcription factor-binding domain of the coactivator CBP is essential for long-term memory and the expression of specific target genes. Learn Mem 13: 609–617. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Vecsey CG, Hawk JD, Lattal KM, Stein JM, Fabian SA, et al. (2007) Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J Neurosci 27: 6128–6140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Oliveira AM, Wood MA, McDonough CB, Abel T (2007) Transgenic mice expressing an inhibitory truncated form of p300 exhibit long-term memory deficits. Learn Mem 14: 564–572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Oliveira AM, Estévez MA, Hawk JD, Grimes S, Brindle PK, et al. (2011) Subregion-specific p300 conditional knock-out mice exhibit long-term memory impairments. Learn Mem 18: 161–169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. He L, Sabet A, Djedjos S, Miller R, Sun X, et al. (2009) Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB Binding Protein. Cell 137: 635–646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Zhou XY, Shibusawa N, Naik K, Porras D, Temple K, et al. (2004) Insulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein. Nat Med 10: 633–637. [DOI] [PubMed] [Google Scholar]
- 30. Bedford DC, Kasper LH, Wang R, Chang Y, Green DR, et al. (2011) Disrupting the CH1 domain structure in the acetyltransferases CBP and p300 results in lean mice with increased metabolic control. Cell Metab 14: 219–230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Gayther, SA Batley SJ, Linger L, Bannister A, Thorpe K, et al.. (2000) Mutations truncating the EP300 acetylase in human cancers. Nat Genet 24, 300–303. [DOI] [PubMed]
- 32. Iyer NG, Ozdag H, Caldas C (2004) p300/Cbp and cancer. Oncogene 23: 4225–4231. [DOI] [PubMed] [Google Scholar]
- 33. Petrij F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RC, et al. (1995) Rubinstein-Taybi syndrome caused by mutations in the transcriptional coactivator CBP. Nature 376: 348–51. [DOI] [PubMed] [Google Scholar]
- 34. Zimmermann N, Acosta AM, Kohlhase J, Bartsch O (2007) Confirmation of EP300 gene mutations as a rare cause of Rubinstein-Taybe syndrome. Eur J Hum Genet 15: 837–842. [DOI] [PubMed] [Google Scholar]
- 35. Kalkhoven E, Roelfsema JH, Teunissen H, den Boer A, Ariyurek Y, et al. (2003) Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome. Hum Molec Genet 12: 441–450. [DOI] [PubMed] [Google Scholar]
- 36. Murata T, Kurokawa R, Krones A, Tatsumi K, Ishii M, et al. (2001) Defects of acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome. Hum Molec Genet 10: 1071–1076. [DOI] [PubMed] [Google Scholar]
- 37. Tanaka Y, Naruse I, Hongo T, Xu M, Nakahata T, et al. (2000) Extensive brain hemorrhage and embryonic lethality in a mouse null mutant of CREB-binding protein. Mech Dev 95: 133–145. [DOI] [PubMed] [Google Scholar]
- 38. Yao TP, Oh SP, Fuchs M, Zhou ND, Ch'ng LE, et al. (1998) Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93: 361–372. [DOI] [PubMed] [Google Scholar]
- 39. Kang-Decker N, Tong C, Boussouar F, Baker DJ, Xu W, et al. (2004) Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency. Cancer Cell 5: 177–189. [DOI] [PubMed] [Google Scholar]
- 40. van Genderen MM, Kinds GF, Riemslag FC, Hennekam RC (2000) Ocular features in Rubinstein-Taybi syndrome: investigation of 24 patients and review of the literature. Br J Ophthalmol 84: 1177–1184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Yanagi Y, Masuhiro Y, Mori M, Yanagisawa J, Kato S (2000) p300/CBP acts as a coactivator of the cone-rod homeobox transcription factor. Biochem Biophys Res Commun 269: 410–414. [DOI] [PubMed] [Google Scholar]
- 42. Gaub P, Joshi Y, Wuttke A, Naumann U, Schnichels S, et al. (2011) The histone acetyltransferase p300 promotes intrinsic axonal regeneration. Brain 134: 2134–2148. [DOI] [PubMed] [Google Scholar]
- 43. Hao H, Tummala P, Guzman E, Mali RS, Gregorski J, et al. (2001) The transcription factor Neural Retina Leucine Zipper (NRL) controls photoreceptor-specific expression of Myocyte Enhancer Factor Mef2c from an alternative promoter. J Biol Chem 286: 34893–34902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Solovei I, Kreysing M, Lanctot C, Kosem S, Peichl L, et al. (2009) Nuclear architecture of rod photoreceptor cells adapts to vision in mammalian evolution. Cell 137: 356–368.44. [DOI] [PubMed] [Google Scholar]
- 45. Li S, Chen D, Sauvé Y, McCandless J, Chen YJ, et al. (2005) Rhodopsin-iCre transgenic mouse line for Cre-mediated rod-specific gene targeting. Genesis 41: 73–80. [DOI] [PubMed] [Google Scholar]
- 46. Le YZ, Ash JD, Al-Ubaidi MR, Chen Y, Ma JX, et al. (2004) Targeted expression of Cre recombinase to cone photoreceptors in transgenic mice. Mol Vision 10: 1011–1018. [PubMed] [Google Scholar]
- 47. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L (2007) A global double-fluorescent Cre reporter mouse. Genesis 45: 593–605. [DOI] [PubMed] [Google Scholar]
- 48. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493–501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Chen J, Nathans J (2007) Genetic ablation of cone photoreceptors eliminates retinal folds in the retinal degeneration 7 (rd7) mouse. Invest Ophthalmol Vis Sci 48: 2799–2805. [DOI] [PubMed] [Google Scholar]
- 50. Kizilyaprak C, Spehner D, Devys D, Schultz P (2010) In Vivo chromatin organization of mouse rod photoreceptors correlates with histone modifications. PLoS ONE 5(6): e11039 doi:10.1371/journal.pone.0011039 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Blackshaw S, Harpavat S, Trimarchi J, Cai L, Huang H, et al. (2004) Genomic analysis of mouse retinal development. PLoS Biol 2(9): e247 and http://genepath.med.harvard.edu/~cepko/SAGE/index.html. [DOI] [PMC free article] [PubMed]
- 52. Hsiau TH-C, Diaconu C, Myers CA, Lee J, Cepko CL, et al. (2007) The Cis-regulatory Logic of the Mammalian Photoreceptor Transcriptional Network. PLoS ONE 2(7): e643 doi:10.1371/journal.pone.0000643 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Livesey FJ, Furukawa T, Steffen MA, Church GM, Cepko CL (2000) Microarray analysis of the temporal network controlled by the photoreceptor homeobox gene Crx. Curr Biol 10: 301–310. [DOI] [PubMed] [Google Scholar]
- 54. Mears AJ, Kondo M, Swain PK, Takada Y, Bush RA, et al. (2001) Nrl is required for rod photoreceptor development. Nature Genetics 29: 447–452. [DOI] [PubMed] [Google Scholar]
- 55. Daniele LL, Lillo C, Lyubarsky AL, Nikonov SS, Philip N, et al. (2005) Cone-like morphological, molecular, and electrophysiological features of the photoreceptors of the Nrl knockout mouse. Invest Ophthalmol Vis Sci 46: 2156–2167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Valor LM, Pulopulos MM, Jimenez-Minchan M, Olivares R, Lutz B, et al. (2011) Ablation of CBP in forebrain principal neurons causes modest memory and transcriptional defects and a dramatic reduction of histone acetylation but does not affect cell viability. J Neurosci 31: 1652–1663. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Ramos YFM, Hestand MS, Verlaan M, Krabbendam E, Ariyurek Y, et al. (2010) Genome-wide assessment of differential roles for p300 and CBP in transcription regulation. Nucl Acids Res 38: 5396–5408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Yang Y, Wolf LV, Cvekl A (2007) Distinct embryonic expression and localization of CBP and p300 histone acetyltransferases at the mouse aA-Crystallin locus in lens. J Mol Biol 369: 917–926. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Lambard S, Reichman S, Berlinicke C, Niepon M-L, Goureau O, et al. (2010) Expression of Rod-Derived Cone Viability Factor: Dual Role of CRX in Regulating Promoter Activity and Cell-Type Specificity. PLoS ONE 5(10): e13075 doi:10.1371/journal.pone.0013075 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Jaillard C, Mouret A, Niepon ML, Clérin E, Yang Y, et al. (2012) Nxnl2 splicing results in dual functions in neuronal cell survival and maintenance of cell integrity. Hum Mol Genet 21: 2298–2311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Marc RE, Jones BW, Watt CB, Strettoi E (2003) Neural remodeling in retinal degeneration. Prog Retin Eye Res 22: 607–655. [DOI] [PubMed] [Google Scholar]
- 62. Haider NB, Naggert JK, Nishina PM (2001) Excess cone cell proliferation due to lack of a functional NR2E3 causes retinal dysplasia and degeneration in rd7/rd7 mice. Hum Mol Genet 10: 1619–1626. [DOI] [PubMed] [Google Scholar]
- 63. Mehalow AK, Kameya S, Smith RS, Hawes NL, Denegre JM, et al. (2003) CRB1 is essential for external limiting membrane integrity and photoreceptor morphogenesis in the mammalian retina. Hum Mol Genet 12: 2179–2189. [DOI] [PubMed] [Google Scholar]
- 64. de Melo J, Miki K, Rattner A, Smallwood P, Zibetti C, et al. (2012) Injury-dependent induction of reactive gliosis in retina by loss of function of the LIM homeodomain transcription factor Lhx2. Proc Natl Acad Sci USA 109: 4657–4662. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Van de Pavert SA, Kantardzhieva A, Malysheva A, Meuleman J, Versteeg I, et al. (2004) Crumbs homolog 1 is required for maintenance of photoreceptor cell polarization and adhesion during light exposure. J Cell Sci 117: 4169–4177. [DOI] [PubMed] [Google Scholar]
- 66. Stuck MW, Conley SM, Naash MI (2012) Defects in the outer limiting membrane are associated with rosette development in the Nrl−/− retina. PLoS One 7(3): e32484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Helmlinger D, Hardy S, Abou-Sleymane G, Eberlin A, Bowman AB, et al. (2006) Glutamine-expanded ataxin-7 alters TFTC/STAGA recruitment and chromatin structure leading to photoreceptor dysfunction. PLoS Biol 4(3): e67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Campisi J, d'Adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nature Rev Mol Cell Biol 8: 729–740. [DOI] [PubMed] [Google Scholar]
- 69. Blobel GA (2000) CREB-binding protein and p300: molecular integrators of hematopoietic transcription. Blood 95: 745–755. [PubMed] [Google Scholar]
- 70. Lagali PS, Picketts DJ (2011) Matters of life and death: the role of chromatin remodeling proteins in retinal neuron survival. J Ocul Biol Dis Inform 4: 111–120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Chinnadurai G, Vijayalingam S, Rashmi R (2009) BIK, the founding member of the BH3-only family of protins: mechanisms of cell death and role in cancer and pathogenic processes. Oncogene 27, S20–S29. [DOI] [PMC free article] [PubMed]
- 72. La Spada AR, Fu YH, Sopher BL, Libby RT, Wang X, et al. (2001) Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7. Neuron 31: 913–927. [DOI] [PubMed] [Google Scholar]
- 73. Palhan VB, Chen S, Peng GH, Tjernberg A, Gamper AM, et al. (2005) Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration. Proc Natl Acad Sci USA 102: 8472–8477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Solovei I, Wang AS, Thanisch K, Schmidt CS, Krebs S, et al. (2013) LBR and Lamin A/C sequentially tether peripheral heterochromatin and inversely regulate differentiation. Cell 152: 584–598. [DOI] [PubMed] [Google Scholar]
- 75. Jia L, Oh ECT, Ng L, Srinivas M, Brooks M, et al. (2009) Retinoid-related orphan nuclear receptor RORß is an early-acting factor in rod photoreceptor development. Prod Natl Acad Sci USA 106: 17534–17539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Donovan SL, Schweers B, Martins R, Johnson D, Dyer MA (2006) Compensation by tumor suppressor genes during retinal development in mice and humans. BMC Biol 4: 1–14 Doi:10.1186/1741-7007-4-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. Gonzalo S, Blasco MA (2005) Role of Rb family in the epigenetic definition of chromatin. Cell Cycle 4: 752–755. [DOI] [PubMed] [Google Scholar]
- 78. Macaluso M, Montanari M, Noto PB, Gregorio V, Surmacz E, et al. (2006) Nuclear and cytoplasmic interaction of pRb2/p130 and ER-beta in MCF-7 breast cancer cells. Ann Oncol 17 Suppl 727–29. [DOI] [PubMed] [Google Scholar]
- 79. Longworth MS, Dyson NJ (2010) pRb, a local chromatin organizer with global possibilities. Chromosoma 119: 1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80. Peng G-H, Chen S (2011) Active opsin loci adopt intrachromosomal loops that depend on the photoreceptor transcription factor network. Proc Natl Acad Sci USA 108: 17821–1782. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81. Gimenez E, Montoliu L (2001) A simple polymerase chain reaction assay for genotyping the retinal degeneration mutation (Pdebrd1) in FVB/N-derived transgenic mice. Lab Anim 35: 153–154 DOI:10.1258/0023677011911525 [DOI] [PubMed] [Google Scholar]
- 82. Mattapallil MJ, Wawrousek EF, Chan CC, Zhao H, Roychoudhury J, et al. (2012) The rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest Ophthalmol Vis Sci 53: 2921–2927. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Shechter D, Dormann HL, Allis CD, Hake SB (2009) Extraction, purification, and analysis of histones. Nature Protocols 2(6): 1445–1457. [DOI] [PubMed] [Google Scholar]
- 84. Chen S, Peng GH, Wang X, Smith AC, Grote SK, et al. (2004) Interference of Crx-dependent transcription by ataxin-7 involves interaction between the glutamine regions and requires the ataxin-7 carboxy-terminal region for nuclear localization. Hum Molec Genet 13: 53–67. [DOI] [PubMed] [Google Scholar]
- 85.Peng G-H, Chen S (2005) Chromatin immunoprecipitation identifies photoreceptor transcription factor targets in mouse models of retinal degeneration: New findings and challenges. Vis Neurosci 22, 575–586. [DOI] [PubMed]
- 86. Peng G-H, Ahmad O, Ahmad F, Liu J, Chen S (2005) The photoreceptor-specific nuclear receptor Nr2e3 interacts with Crx and exerts opposing effects on the transcription of rod versus cone genes. Hum Molec Genet 14: 747–764. [DOI] [PubMed] [Google Scholar]
- 87. Bustin SA, Benes V, Garson JA, Hellemans J, Huggert J, et al. (2009) The MIQE Guidelines: Minimum Information for publication of Quantitative real-time PCR Experiments. Clinical Chemistry 55: 611–622. [DOI] [PubMed] [Google Scholar]
- 88. Taylor S, Wakem M, Dijkman G, Alsarraj M, Nguyen M (2010) A practical approach to RT-qPCR – publishing data that conform to the MIQE guidelines. Methods 50: S1–S5. [DOI] [PubMed] [Google Scholar]
- 89. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM (2000) A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Current Biology 10: 886–895. [DOI] [PubMed] [Google Scholar]
- 90. Gerdes J, Lemke H, Baisch H, Wacher H-H, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710–1715. [PubMed] [Google Scholar]
- 91. Wei Y, Yu L, Bowen J, Gorovsky MA, Allis DC (1999) Phosphorylation of Histone He is required for proper chromosome condensation and segregation. Cell 97: 99–109. [DOI] [PubMed] [Google Scholar]
- 92. Davis DM, Dyer MA (2010) Retinal progenitor cells, differentiation, and barriers to cell cycle reentry. Curr Top Devel Biol 93: 175–188. [DOI] [PubMed] [Google Scholar]
- 93. Bassett EA, Wallace VA (2012) Cell fate determination in the vertebrate retina. Trends Neurosci 35: 565–573. [DOI] [PubMed] [Google Scholar]
- 94. Seo S, Kroll KL (2006) Geminin's double life: chromatin connections that regulate transcription at the transition from proliferation to differentiation. Cell Cycle 5: 374–379. [DOI] [PubMed] [Google Scholar]
- 95. Spella M, Kyrousi C, Kritikou E, Stathopoulou A, Guillemot F, Kioussis D, Pachnis V, Lygerou Z, Taraviras S (2011) Geminin regulates cortical progenitor proliferation and differentiation. Stem Cells 29: 1269–1282. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.